NYSE:BSX

Boston Scientific Stock Forecast, Price & News

$44.12
+0.57 (+1.31 %)
(As of 07/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$43.69
$44.27
50-Day Range
$41.23
$44.12
52-Week Range
$32.99
$44.63
Volume5.20 million shs
Average Volume5.56 million shs
Market Capitalization$62.69 billion
P/E Ratio441.20
Dividend YieldN/A
Beta0.88
30 days | 90 days | 365 days | Advanced Chart
Receive BSX News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.


Boston Scientific logo

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.73 out of 5 stars

Medical Sector

258th out of 2,215 stocks

Surgical & Medical Instruments Industry

24th out of 181 stocks

Analyst Opinion: 2.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Boston Scientific (NYSE:BSX) Frequently Asked Questions

Is Boston Scientific a buy right now?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 5 hold ratings, 13 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Boston Scientific stock.
View analyst ratings for Boston Scientific
or view top-rated stocks.

What stocks does MarketBeat like better than Boston Scientific?

Wall Street analysts have given Boston Scientific a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Boston Scientific wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Boston Scientific?

Boston Scientific saw a decline in short interest in June. As of June 30th, there was short interest totaling 47,400 shares, a decline of 99.6% from the June 15th total of 13,400,000 shares. Based on an average daily volume of 7,000,000 shares, the short-interest ratio is currently 0.0 days.
View Boston Scientific's Short Interest
.

When is Boston Scientific's next earnings date?

Boston Scientific is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021.
View our earnings forecast for Boston Scientific
.

How can I listen to Boston Scientific's earnings call?

Boston Scientific will be holding an earnings conference call on Tuesday, July 27th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) issued its quarterly earnings results on Tuesday, April, 27th. The medical equipment provider reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.06. The medical equipment provider had revenue of $2.75 billion for the quarter, compared to analysts' expectations of $2.62 billion. Boston Scientific had a net margin of 1.69% and a trailing twelve-month return on equity of 9.80%. Boston Scientific's quarterly revenue was up 8.2% on a year-over-year basis. During the same period last year, the company earned $0.28 EPS.
View Boston Scientific's earnings history
.

How has Boston Scientific's stock been impacted by COVID-19 (Coronavirus)?

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BSX shares have increased by 30.3% and is now trading at $44.12.
View which stocks have been most impacted by COVID-19
.

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific issued an update on its FY 2021 earnings guidance on Wednesday, May, 5th. The company provided earnings per share (EPS) guidance of 1.530-1.600 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.540. The company issued revenue guidance of $11.50 billion-$11.80 billion, compared to the consensus revenue estimate of $11.43 billion.

What price target have analysts set for BSX?

19 equities research analysts have issued 12-month target prices for Boston Scientific's shares. Their forecasts range from $42.74 to $52.00. On average, they expect Boston Scientific's share price to reach $46.99 in the next year. This suggests a possible upside of 6.5% from the stock's current price.
View analysts' price targets for Boston Scientific
or view top-rated stocks among Wall Street analysts.

Who are Boston Scientific's key executives?

Boston Scientific's management team includes the following people:

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific CEO Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among Boston Scientific's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Boston Scientific's key competitors?

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), The Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and salesforce.com (CRM).

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by many different institutional and retail investors. Top institutional investors include TCW Group Inc. (0.18%), Manning & Napier Group LLC (0.03%), TIAA FSB (0.03%), Welch & Forbes LLC (0.03%), Gradient Investments LLC (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Arthur C Butcher, Daniel J Brennan, David A Pierce, David A Pierce, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, Jeffrey B Mirviss, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Scott Olson, Wendy Carruthers, William F Bruss and Williamson Scott.
View institutional ownership trends for Boston Scientific
.

Which institutional investors are selling Boston Scientific stock?

BSX stock was sold by a variety of institutional investors in the last quarter, including TIAA FSB, TCW Group Inc., Manning & Napier Group LLC, State of Alaska Department of Revenue, Fulton Bank N.A., and Welch & Forbes LLC. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Edward F Mackey, Jeffrey B Mirviss, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Scott Olson, Wendy Carruthers, and William F Bruss.
View insider buying and selling activity for Boston Scientific
or view top insider-selling stocks.

Which institutional investors are buying Boston Scientific stock?

BSX stock was purchased by a variety of institutional investors in the last quarter, including Gradient Investments LLC, IFM Investors Pty Ltd, BNC Wealth Management LLC, CHICAGO TRUST Co NA, Raymond James Trust N.A., New Mexico Educational Retirement Board, Stratos Wealth Partners LTD., and Tranquility Partners LLC.
View insider buying and selling activity for Boston Scientific
or or view top insider-buying stocks.

How do I buy shares of Boston Scientific?

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $44.12.

How much money does Boston Scientific make?

Boston Scientific has a market capitalization of $62.69 billion and generates $9.91 billion in revenue each year. The medical equipment provider earns $-82,000,000.00 in net income (profit) each year or $0.96 on an earnings per share basis.

How many employees does Boston Scientific have?

Boston Scientific employs 38,000 workers across the globe.

Does Boston Scientific have any subsidiaries?

The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.

When was Boston Scientific founded?

Boston Scientific was founded in 1979.

What is Boston Scientific's official website?

The official website for Boston Scientific is www.bostonscientific.com.

Where are Boston Scientific's headquarters?

Boston Scientific is headquartered at 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752.

How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at (508) 683-4000 or via email at [email protected]


This page was last updated on 7/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.